New drug targets Hard-to-Treat colorectal cancer in early trial
Disease control
Recruiting now
This study tests a new drug, tegavivint, in people with metastatic colorectal cancer that has worsened after at least two prior treatments. The trial aims to find a safe dose and see if the drug shrinks tumors when used alone or with standard therapies. About 126 adults with spec…
Phase: PHASE1, PHASE2 • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC